자동 굴절 검사기 및 각막 곡률 측정기 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of autorefractor and keratometer Market

The global autorefractor and keratometer market was valued at USD 73.26 million in 2025 and is projected to grow from USD 77.1 million in 2026 to USD 120.19 million by 2034, registering a CAGR of 5.71% during the forecast period. North America dominated the market in 2025, supported by advanced healthcare infrastructure and strong adoption of ophthalmic diagnostic technologies.

Autorefractors and keratometers are essential ophthalmic instruments used to measure refractive errors and corneal curvature. An autorefractor evaluates how light changes as it enters the eye to determine refractive error, while a keratometer measures the curvature of the cornea. Hybrid devices, commonly known as autorefractor-keratometers (ARKs), combine both functions, offering comprehensive eye assessments in a single system.

The rising burden of ocular disorders such as hyperopia, myopia, astigmatism, cataracts, and diabetic retinopathy is significantly driving demand for advanced diagnostic equipment worldwide. Key players operating in the market include Topcon Corporation, NIDEK CO., LTD., Carl Zeiss Meditech AG, EssilorLuxottica, and CANON MEDICAL SYSTEMS CORPORATION.

Market Drivers

Rising Prevalence of Ocular Diseases

Increasing incidence of vision disorders is a major growth driver. Lifestyle changes, rising screen time, an aging population, and growing diabetic cases are contributing to higher rates of refractive errors. According to global studies, myopia cases are projected to affect nearly half of the world's population by 2050.

Governments and healthcare organizations are emphasizing early diagnosis and preventive eye care. Regular eye screening initiatives and awareness programs are increasing the utilization of autorefractors and keratometers in hospitals and clinics, thereby supporting steady market expansion.

Market Restraints

Limited Awareness and High Device Costs

Despite technological advancements, limited awareness of routine eye examinations in low- and middle-income countries restrains market growth. Additionally, high-end autorefractor models can cost over USD 25,000, making them less accessible for smaller healthcare facilities.

Affordability concerns and delayed diagnosis due to lack of awareness may limit device penetration, especially in resource-constrained regions.

Market Opportunities

Strategic Partnerships and Technological Innovation

Rising collaborations, mergers, and acquisitions among key players are creating growth opportunities. Companies are investing in R&D to develop portable and AI-integrated diagnostic devices.

For instance, Carl Zeiss Meditech AG strengthened its ophthalmic portfolio through acquisitions aimed at enhancing digital workflow and advanced diagnostics. Increasing innovation in handheld and automated devices is expected to expand product adoption across developed and emerging markets.

Market Challenges

Shortage of Skilled Ophthalmic Professionals

A shortage of trained ophthalmic technicians and specialists presents a key challenge. Workforce imbalance limits the effective utilization of advanced diagnostic equipment, particularly in rural and underserved regions. This may reduce patient access to timely eye diagnosis and treatment.

Market Trends

Integration of AI and Digital Technologies

Technological advancements are reshaping the diagnostic landscape. Modern autorefractors and keratometers now feature digital displays, automated focusing, high-resolution imaging, cloud integration, and electronic health record (EHR) compatibility.

The integration of artificial intelligence (AI) and machine learning (ML) enables real-time analytics and precision diagnostics. These innovations improve accuracy in detecting cataracts, keratoconus, and subtle corneal abnormalities, boosting adoption across ophthalmic practices.

Impact of COVID-19

The COVID-19 pandemic negatively impacted market growth due to reduced patient visits and postponed elective examinations. Several companies experienced revenue declines in 2020. However, with the resumption of healthcare services in 2021, patient visits recovered, and the market gradually returned to its pre-pandemic growth trajectory.

Segmentation Analysis

By Product Type

The market is segmented into autorefractor, keratometer, and hybrid devices.

The hybrid segment (ARKs) is expected to hold a dominant share due to its high accuracy and dual-function capability. The autorefractor segment is projected to witness steady growth with AI-enabled enhancements.

By Portability

Based on portability, the market is divided into tabletop and handheld devices.

The tabletop segment dominates due to its widespread use in optometric offices and hospitals. The handheld segment is growing rapidly, driven by demand for portable diagnostic solutions in mobile clinics and rural outreach programs.

By Indication

The market includes hyperopia, myopia, astigmatism, and others.

The hyperopia segment held a significant share in 2024 due to its rising prevalence among adults and children. Myopia is projected to grow steadily due to increasing digital device usage.

By End-user

The market is segmented into hospitals, ophthalmic clinics, and others.

Hospitals dominated in 2024 due to higher patient volume and access to advanced equipment. Ophthalmic clinics are expected to grow at the fastest CAGR due to increasing specialized eye care centers.

Regional Outlook

North America

North America dominated the market in 2025, with a value of USD 26.65 million. Strong reimbursement policies, rising diabetic cases, and advanced healthcare infrastructure are key growth drivers.

Europe

Europe holds a substantial share due to strict medical device regulations and a large ophthalmologist base, supporting higher diagnostic rates.

Asia Pacific

Asia Pacific is projected to grow at the fastest CAGR due to rising healthcare investments and a large patient pool in countries such as China, India, and Japan.

Latin America & Middle East & Africa

These regions are witnessing moderate growth, supported by improving healthcare infrastructure and increasing government investments.

Competitive Landscape

The market is consolidated, with leading players such as Carl Zeiss Meditech AG, Topcon Corporation, and NIDEK CO., LTD. focusing on product innovation, partnerships, and geographic expansion. Companies are emphasizing AI integration, portability, and digital connectivity to gain a competitive edge.

Conclusion

The global autorefractor and keratometer market is expected to grow steadily from USD 73.26 million in 2025 to USD 120.19 million by 2034, driven by the rising prevalence of ocular diseases, technological advancements, and increasing emphasis on early diagnosis. While high device costs and workforce shortages present challenges, expanding healthcare infrastructure, AI-enabled innovations, and growing awareness of preventive eye care will support long-term market expansion worldwide.

Segmentation By Product Type

• Autorefractor
• Keratometer
• Hybrid

By Portability

• Tabletop
• Handheld

By Indication

• Hyperopia
• Myopia
• Astigmatism
• Others

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Region

• North America (By Product Type, Portability, Indication, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Conditions, By Key Countries/Region, 2025
• 4.2. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
• 4.3. New Product Launch/Approvals, By Key Players

5. Global Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Autorefractor
  • 5.1.2. Keratometer
  • 5.1.3. Hybrid
• 5.2. Market Analysis, Insights and Forecast - By Portability
  • 5.2.1. Tabletop
  • 5.2.2. Handheld
• 5.3. Market Analysis, Insights and Forecast - By Indication
  • 5.3.1. Hyperopia
  • 5.3.2. Myopia
  • 5.3.3. Astigmatism
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals
  • 5.4.2. Ophthalmic Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Autorefractor
  • 6.1.2. Keratometer
  • 6.1.3. Hybrid
• 6.2. Market Analysis, Insights and Forecast - By Portability
  • 6.2.1. Tabletop
  • 6.2.2. Handheld
• 6.3. Market Analysis, Insights and Forecast - By Indication
  • 6.3.1. Hyperopia
  • 6.3.2. Myopia
  • 6.3.3. Astigmatism
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals
  • 6.4.2. Ophthalmic Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Autorefractor
  • 7.1.2. Keratometer
  • 7.1.3. Hybrid
• 7.2. Market Analysis, Insights and Forecast - By Portability
  • 7.2.1. Tabletop
  • 7.2.2. Handheld
• 7.3. Market Analysis, Insights and Forecast - By Indication
  • 7.3.1. Hyperopia
  • 7.3.2. Myopia
  • 7.3.3. Astigmatism
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals
  • 7.4.2. Ophthalmic Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Autorefractor
  • 8.1.2. Keratometer
  • 8.1.3. Hybrid
• 8.2. Market Analysis, Insights and Forecast - By Portability
  • 8.2.1. Tabletop
  • 8.2.2. Handheld
• 8.3. Market Analysis, Insights and Forecast - By Indication
  • 8.3.1. Hyperopia
  • 8.3.2. Myopia
  • 8.3.3. Astigmatism
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals
  • 8.4.2. Ophthalmic Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Autorefractor
  • 9.1.2. Keratometer
  • 9.1.3. Hybrid
• 9.2. Market Analysis, Insights and Forecast - By Portability
  • 9.2.1. Tabletop
  • 9.2.2. Handheld
• 9.3. Market Analysis, Insights and Forecast - By Indication
  • 9.3.1. Hyperopia
  • 9.3.2. Myopia
  • 9.3.3. Astigmatism
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals
  • 9.4.2. Ophthalmic Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Autorefractor
  • 10.1.2. Keratometer
  • 10.1.3. Hybrid
• 10.2. Market Analysis, Insights and Forecast - By Portability
  • 10.2.1. Tabletop
  • 10.2.2. Handheld
• 10.3. Market Analysis, Insights and Forecast - By Indication
  • 10.3.1. Hyperopia
  • 10.3.2. Myopia
  • 10.3.3. Astigmatism
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals
  • 10.4.2. Ophthalmic Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Carl Zeiss Meditech AG
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. EssilorLuxottica
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Topcon Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. NIDEK CO., LTD.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Bausch + Lomb
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. CANON MEDICAL SYSTEMS CORPORATION
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Remidio Innovative Solutions Pvt Ltd.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Visionix
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)